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Introduction
In today’s world, prolonged wakefulness can be 
considered as a widespread phenomenon which probably 
occurs because of acute total sleep deprivation (TSD) 
or chronic partial sleep limitation.1 Birds and mammals 
represent two distinguished kinds of sleep including non-
rapid eye movement (NREM) and rapid eye movement 
(REM) which can be distinguished fairly easily using 
electroencephalogram (EEG) and electromyogram 
(EMG).2,3
Studies have shown that sleep is essential to maintain 
energy, regulate heat, and recover tissues4; moreover, it is 
beneficial for proper cognitive functions.5,6 On the other 
hand, it seems that lack of sleep or sleep disorder will have 
reverse effects which may cause cognitive deficiencies such 
as impairment in attention, decision making, learning, 
and various kinds of memory.5,6 Furthermore, lack of sleep 
activates sympathetic system and leads to hypertension as 
well as increased cortisol,7 while immune responses are 
impaired 8 and changes in mood are observed.9
Hippocampus is one of brain areas which is definitely 
important in most cognitive functions.10 Hippocampal 
formations receive multi-modal sensory data which is 
provided by different cortical bases, play a significant role 
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Abstract
Background: Sleep disorder or sleep deprivation (SD) is a common issue in today’s society. Numerous 
evidences show that sleep is essential for proper brain performance and cognitive processes; on the 
other hand, cognitive functions have a broad range with learning and long-term memory as the 
most important ones related to attention. Since many studies show that cholinergic system has a 
significant role in sleep, learning, and memory, this study aims to investigate the impacts of CA1 
Cholinergic Nicotinic Receptors on memory acquisition deficit which is stimulated by total sleep 
deprivation (TSD) and REM sleep deprivation (RSD).
Methods: In this study a water box or a multi-platform apparatus was used in order to induce 
TSD or RSD. In order to investigate interactions of cholinergic system and hippocampus-dependent 
memory, nicotinic receptor agonist (nicotine) or nicotinic receptor antagonist (mecamylamine) was 
injected in hippocampal CA1.
Results: According to the results of this study, 24 hours TSD or RSD decreased memory acquisition 
and injection of nicotine (0.0001 µg/rat) or mecamylamine (0.001 µg/rat) in TSD and RSD sham 
groups didn’t change memory acquisition. However, injection of sub-threshold dose of nicotine 
(0.0001 µg/rat) and mecamylamine (0.001 µg/rat) could reduce negative effects of SD in both TSD 
and RSD. 
Conclusion: According to the present study, cholinergic nicotinic receptors are effective in learning 
and memory improvement.
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in memory processes, learning, spatial coding, and also 
regulate emotional behaviors and anxiety.11
Numerous studies performed on humans and animals 
have indicated that pre-training SD leads to impairment 
of learning and memory coding in different types of 
tasks.6 In addition, it seems that hippocampus-dependent 
stabilization of memory is especially sensitive to sleep 
disorder during sleep phase immediately after learning 
and memory consolidation.11
In fact, studies which have investigated the impacts 
of sleep on learning have indicated the significance of 
sleep in stabilization of memory and have introduced 
hippocampus as a susceptible target due to outcomes 
associated with lack of sleep or sleep disorder.11
Existing evidence shows that SD may impair processes 
of neuronal formation in hippocampus and memory 
through reduction in LTP,12,13 reduction of cAMP/
PKA signaling,5,13 reduction of glutamate receptors’ 
performance and expression.14,15. Decreasing transcription 
of CREB intermediary gene, and finally neurotropic 
gene.16
Different stages of sleep and wakefulness are dependent 
on specific types of neurotransmitters and their specialized 
receptors such as acetyl choline, serotonin, glutamate, and 
so on like other animal functions.17,18
Acetyl choline is secreted by all neurons in CNS and 
is also found in basal forebrain. This structure sends its 
branches into hippocampus, neuro-cortex, and poly-
midbrain cholinergic complex after which it is divided 
and its branches go to posterior thalamus and anterior 
brain.17,19 It seems that this system has a significant role in 
sleep, wakefulness, learning and memory.20
Acetyl choline is produced in cholinergic neuron 
terminals by choline acetyl transferase enzyme (chAT) 
and is hydrolyzed by acetyl choline esterase in synaptic 
cleft after it has established its effects.21
Traditionally, acetyl choline receptors are divided into 
two main groups of muscarinic cholinergic receptors and 
nicotinic cholinergic receptors based on pharmacologic 
features. Both muscarinic and nicotinic receptors are 
found in great amounts in the brain. Acetyl choline 
nicotinic receptors are members of a superfamily of 
ligand gate ionic channels.22,23 Cholinergic nicotinic 
receptors in the brain are mostly located on glutamate 
secreted axon terminals as presynaptic and facilitate 
release of this transmitter.24 However, some are post 
synaptic. Muscarinic cholinergic receptors are completely 
different from nicotinic receptors. Large amounts of five 
different types of muscarinic cholinergic receptors are 
expressed in brain five separate simulation genes and 
most of them act through protein G-coupled receptors.21 
Posterior hippocampus or CA1 which has a significant 
role in learning and memory includes high amounts of 
cholinergic receptors.25
In the present study, both TSDs and RSDs are expected 
to reduce memory acquisition, activate nAchRs of 
hippocampus CA1 area, provide suitable conditions for 
neuronal plasticizing and LTP production, and improve 
memory acquisition, and since the concentration of Ach 
increases during the RAM sleep and decreases during 
NREM sleep,20 and given the fact that there is RSD in the 
TSD as well, it is also possible that the 2 groups respond 
similarly to the activation of nAchRs.
It is also expected that the blockage of nAchRs by 
mecamylamine, followed by SD, will reduce memory 
acquisition.
Since people’s quality of life may change due to the 
effects of lack of sleep, and given that some questions 
are still unanswered regarding sleep function and the 
effects due to lack of sleep, and also considering the close 
relationship between sleep and wakefulness as well as 
cholinergic system and cognitive performance, this study 
aims to examine the role which is played by posterior 
hippocampus (CA1) cholinergic nicotinic receptors in 
amnesia due to RSD and TSD.
Methods and Materials
Animals
Male Wistar rats with a weight range of 220-250 g were 
provided from Institute for Cognitive Science Studies 
(ICSS) and were then used in the experiments of the 
present study. Plexiglas cages were used to keep animals 
in groups of four members under standard temperature 
(22 ± 2) and light/dark cycle (12/12 hours), while they 
could access water and food (except some short stages 
of the experiment) freely. Each group included 7 male 
rats and each rat was used only once. Application of all 
behavioral tests was done during light phase of light/
dark cycle. All ethical issues were considered during 
experiments.
Stereotactic Surgery
Anesthesia was performed by intra-peritoneal injection 
of ketamine hydrochloride (50 mg/kg) and xylazine 
(5 mg/kg) after which they were located in stereotaxic 
apparatus (Stoelting Company, IL, USA). First of all, head 
hair was removed, then incision of the skin was done 
and the surface of the skull was cleaned. In the following 
step, 22-guage guide cannula (with a diameter of 0.7 mm) 
was placed one millimeter above the desired location 
of injection (bilaterally) based on Paxinos and Watson 
Atlas.26 Stereotaxic coordinates for hippocampus CA1 
areas included AP: -2 mm from bregma, L: ±1.6 sagital 
suture, and V: -1.5 mm from the surface of the skull. Dental 
acrylic helped to fix cannulas. Insertion of stainless steel 
stylets (27-gauge) was done into the guide cannulas in 
order to prevent contamination. Approximately 5-7 days 
were required for animals’ recovery after the operation.27,28
Sleep Deprivation Apparatus
Total Sleep Deprivation
In order to deprive animals from NREM sleep 
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(BorjSanatAzma Co. Tehran, Iran), modified automatic 
TSD apparatus (water box) was used.29
This apparatus consists of a water tank made of clear 
Plexiglas (120×30×50 cm) divided into 4 equal boxes 
(30×30×50 cm), with water temperature being set at 30 
centigrade degrees. Four rats were put together in the tank 
(one rat in each box) with the aim to keep social stability. 
Two small platforms (with diameter of 15 cm) with a 3-mm 
deep edge were located next to each other in the middle 
of the tank, while some holes were prepared at the surface 
of each platform (with diameter of 2 mm) so that water 
could discharge easily through upward movements which 
protected rats against slipping or getting wet. Platform 
movements were done independently and automatically. 
In the start position, both platforms were submerged in 
water surface slightly. Then each platform moved upward 
and downward to force rats move without stopping so 
that they could evade from being in touch with water. 
The speed of movement was set at 1 m/s. Completion 
of each platform rotation required 30 seconds. Every 
platform was in its peak height (10 cm) over water surface 
for 10 seconds (in order to get water and food) (holding 
time) through this period. After this period of time, the 
platform was shifted 60 mm down for 2.5 seconds and was 
instantly raised for 2.5 seconds to the primary position. 
The day before application of various sleep deprivation 
(SD) protocols, the rats were familiarized with the water 
box, so that their stress level was reduced for 30 minutes. 
As a result, the rats learned remaining at the junction of 
two platforms and going from the sinking platform to 
the other one in a short movement. The rats could access 
water and food which was always provided above the box 
freely over this period. Behavioral observations obtained 
during daily SD indicated that rats were awaked 100% of 
the time when platform technique was applied.29
The rats were deprived from sleep for 24 hours (TSD) 
for the purposes of the present study. Standard conditions 
were provided to keep animals (12:12 hours light-dark 
cycle in a temperature under control [22 ± 2ºC]) during 
SD phase. Potential effects of stress because of new 
environment were evaluated using control (Sham) groups 
in similar situations when the apparatus was off.
REM Sleep Deprivation 
Multiple-platform apparatus (BorjSanatAzma Co, Tehran, 
Iran) was used for RSD. To apply this method rats should 
be located in a water tank (90×50×50 cm) consisting of 
some circular platforms with diagonals of 7 cm. In the 
present study each platform was placed 2 cm above water 
level. During experiments the rats were free to move 
through the tank and go from one platform to another. 
In the above mentioned technique when the rats went 
into REM sleep their muscles were relaxed and they fell 
into water which consequently led to their wakefulness. 
Thus, the animals were deprived from REM sleep all the 
time period they spent in water tank. On the other hand, 
platforms with a diagonal of 15 cm were applied for sham 
of RSD animals, so that the animals could have REM sleep 
conveniently. Standard water temperature was monitored 
during this experiment, while light-dark cycle (12/12) 
was also considered and food and water were likewise 
provided for the animals.30 The rats were deprived from 
REM sleep for 24 hours (RSD) in this study.
Intra-CA1 Injection
Removal of stainless steel stylets from the guide cannula 
and replacement with 27-gauge injection needles (1 mm 
lower than the tip of the guide cannula) was performed 
so that drugs could be injected. Drug injections were 
done manually in total volume of 1 µL/rat (0.5 µL per 
each cannula) during a period of 60 seconds and using 
Hamilton syringe (2 µL) while needles were put in the 
place for 60 seconds so that drug injection could be 
facilitated. After returning the stylets the animals were 
transferred into their cages.29
Step-Through Apparatus for Memory Assessment
Passive avoidance learning apparatus included a box 
divided into 2 partitions with equivalent sizes (20×20×30) 
by a wall. A guillotine door was located in the middle 
of the wall with dimensions of 7×9 (cm) and could be 
removed when it was required. One part of the apparatus 
was designed with white Plexiglas walls and floor, while 
a 25 W electric lamp 50 cm above the apparatus floor lit 
this section. The other part was set to be dark with black 
Plexiglas walls, while steel rods with 1 cm intervals from 
each other were located at the floor. These rods were 
connected to a stimulator with a connection wire so that 
foot shocks could be produced during the experiment. An 
insulated stimulator was used to deliver periodic electric 
shocks (50 Hz, 3 seconds, 1 mA intensity) to the grid floor 
of the dark compartment.31
Behavioral Procedures
Training
At least 30 minutes before the experiments, animals were 
moved into the test room. After this step each animal was 
located mildly in the light part of the apparatus. Then the 
guillotine door was opened after five seconds so that the 
animal could enter into the dark part of the apparatus. 
The delay which every animal showed to enter into the 
dark compartment was recorded in this stage. Exclusion 
was based on the delay time and those animals which 
had been waited more than 120 seconds to enter into the 
dark compartment were excluded from the experiments. 
When 4 paws of the animal were totally entered into the 
next compartment, the guillotine door was closed and 
the rat returned to its cage after 10 seconds (habituation 
trial). Application of learning trial was done 30 minutes 
after habituation trial. Five seconds after placement of the 
animal in the light compartment, the guillotine door was 
opened. Immediately after the animal entered into the 
Javad-Moosavi et al
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dark compartment, the door was closed and shock (50 
Hz, 1 mA, 3 seconds) was instantly transferred to animal 
feet through the floor of the dark compartment. After 
20 seconds, removal of the rat from the apparatus was 
performed and the animal was accordingly delivered to 
its cage temporarily. Procedure repetition took place after 
two minutes. Each time the rat entered totally into the 
dark compartment, electric shock was delivered to its feet. 
The end of learning trial was the time in which the rat did 
not leave the light compartment and stayed there for 120 
consecutive seconds. The number of trials (entrance into 
the dark chamber) was recorded and accordingly showed 
that all animals learned with at most 3 trials. This section 
was performed 5 minutes after drug injection.27
Retrieval Test
Retrieval test was implemented 24 hours after training was 
finished so that long-term memory could be identified. 
On the test day electric shock wan not administered. Each 
animal was located in the light compartment for twenty 
seconds after which the door was opened and delay in 
entrance into the dark compartment was recorded during 
the period which lasted for 300 seconds.29
Pain Test
Hot plate apparatus (BorjSanatAzma Co, Tehran, Iran) was 
used in order to evaluate changes in pain threshold. This 
apparatus includes a rectangular cast-iron plate (20×25) 
equipped with a thermostat, power supply (220 W), and 
a holding cylinder (with a diagonal of 20 and height of 30 
cm). Temperature of apparatus was set at 50 ± 1 centigrade 
degree in hot plate tests, while reaction time to thermal 
pain was recorded as licking paws or special changes in 
rats’ steps. Cut-off time of the test was 60 seconds. This 
test was performed for each rat after memory training. 
Results were expressed according to delay time to react to 
pain (pain latency) and based on seconds.32
Locomotor Activity Evaluation
Animals’ locomotion apparatus (BorjSanatAzma Co, 
Tehran, Iran) consisted of a transparent Perspex container 
(with a height of 40×30×30 cm). This apparatus included 
a gray Perspex panel (with a thickness of 2.2×30×30 cm) 
with 16 photocells which separated the container into 
16 squares with equal sizes. Locomotor activities were 
evaluated as the number of movements from one square 
to another during 300 seconds. This test was done at trail 
day.33
Drugs
Drugs that were used in this study had been supplied from 
Tocris (Tocris Bioscience, United Kingdom) and included 
nicotine (nicotinic receptor agonist) and mecamylamine 
(nicotinic receptor antagonist). Preparation of drugs was 
done immediately before application of injections at doses 
of 0.0001, 0.001, 0.01 and 0.1 µg/rat.
Statistical Analysis
The results were evaluated statistically considering 
normal distribution of data and also using independent t 
test or one-way analysis of variance (ANOVA). Following 
significant F value, more analyses were done for paired-
group comparisons with the help of post hoc Tukey tests. 
All data are expressed as mean ± standard error of the 
mean (SEM). In all comparisons, P < 0.05 represented 
statistical significance.
Verification of Cannula Supplies
Each rat was anesthetized after the above mentioned 
test sessions, and 0.05 µL solution of 4% methylene-blue 
was injected into CA1 in order to confirm the site of 
cannulation. Next the rat’s head was separated after which 
removal of the brain and its fixation in formaldehyde 
(10%) for one week was performed. After this period of 
time, the brain was cut and the sites of injections were 
verified according to Paxinos and Watson.26
Experimental Design
Experiment1: Effects of Pre-train Intra-CA1 Injection of 
Nicotine or Mecamylamine on Memory Acquisition, 
Pain and Locomotor Activities
Eight groups of animals have been allocated to the present 
trial. Saline (1 µL/rat), various doses of nicotine (0.0001, 
0.001, 0.01 and 0.1 µg/rat) or mecamylamine (0.001, 0.01 
and 0.1 µg/rat) were applied on the rats. Pre-train drug 
injection was used for all cases. This experiment aimed 
to characterize sub-threshold and effective doses of each 
drug in the normal conditions.
Experiment2: The Impact of TSD on Memory 
Acquisition, Pain and Locomotor Activities in Presence 
and Absence of Nicotine or Mecamylamine
Six groups of animals have been allocated to the present 
trial. Intra-CA1 injection of saline (1 µL/rat), nicotine 
(0.0001 µg/rat) or mecamylamine (0.001 µg/rat), was 
performed for the animals 5 minutes before memory 
training in the sham of TSD or TSD. This experiment 
aimed to identify if sub-threshold dose of drugs in the 
sham condition could improve the reactions which were 
induced by TSD. 
Experiment3: The Impact of RSD on Memory 
Acquisition, Pain and Locomotor Activities in Presence 
and Absence of Nicotine or Mecamylamine
Six groups of animals have been allocated to this 
experiment. The animals received intra-CA1 injection 
of saline (1 µL/rat), nicotine (0.0001 µg/rat) or 
mecamylamine (0.001 µg/rat), 5 minutes before memory 
training in the sham of RSD or RSD. This experiment 
aimed to identify if sub-threshold dose of drugs in the 
sham condition could improve the reactions which were 
induced by RSD.
                                                     Int Clin Neurosci J. Vol 5, No 1, Winter 2018 15
                                                                  CA1 Nicotinic Receptors on Memory Acquisition Deficit
journals.sbmu.ac.ir/Neurosciencehttp
Results
The Impact of Pre-train Intra-CA1 Injection of 
Nicotine and Mecamylamine on Memory, Pain and 
Locomotor Activities
One-way ANOVA and post hoc Tukey test showed that 
intra-CA1 injection of nicotine in the normal rats at doses 
0.001 and 0.1 but not 0.0001 and 0.01 µg/rat reduced 
memory acquisition [F (3, 24) =22.681; P < 0.05; Figure 
1, panel 1A], but it did not alter pain response [F (3, 
24)=4.698, P > 0.05; Figure 1, pane1 2A] while nicotine 
at doses 0.01 and 0.1 but not 0.0001 and 0.001 µg/rat 
increased response induced by loco-motor activity in 
normal rats [F (3, 24)=49.40, P < 0.05; Figure 1, panel 3A].
One-way ANOVA and post hoc Tukey test showed 
that intra-CA1 injection of mecamylamine in the normal 
rats at all doses reduced memory acquisition [F (3, 24) 
=6.252; P<0.05; Figure 1, panel 1B], but it did not alter 
pain response [F (3, 24)=6.592, P > 0.05; Figure 1, pane1 
2B] while mecamylamine at all doses increased response 
induced by loco-motor activity [F (3, 24)=24.69, P < 0.05; 
Figure 1, panel 3B].
In according of these results we selected nicotine at dose 
of 0.0001 µg/rat and mecamylamine at dose of 0.001µg/rat 
as sub-threshold dose of these drugs in next experiments.
The Effects of TSD on Memory Acquisition, Pain 
and Locomotor Activities in Presence and Absence 
of Nicotine and Mecamylamine
One-way ANOVA and post hoc Tukey analysis indicated 
that sub-threshold dose of nicotine and mecamylamine 
(that selected according to previous experiment) did 
not alter memory acquisition [F (2, 18)=2.930; P > 0.05; 
Figure 2, panel 1A], while mecamylamine but not nicotine 
increased time interval required for reaction to pain [F 
(2, 18)=27.653; P < 0.05; Figure 2, panel 2A]. However, 
nicotine but not mecamylamine decreased loco-motor 
activity [F (2, 18)=12.542; P < 0.05; Figure 2, panel 3A].
The t test analysis showed that TSD could significantly 
decrease memory acquisition (t=28; P < 0.05; Figure 2, 
panel 1).and loco-motor activity (t=3.374, P < 0.05; Figure 
2, panel 3) while it increased time interval required for 
reaction to pain (t = 4.95; P < 0.05; Figure 2, panel 2).
 One-Way ANOVA and post hoc Tukey test indicated 
that nicotine and mecamylamine restitute the amnesia 
which has been brought about by TSD [F (2, 18)=12.888, 














































































































































Figure 1. The Effect of Pre-training Intra-CA1 Injection of Nicotine (A) or Mecamylamine (B) on Memory Acquisition (Panel A), Latency 
to Paw Withdraw (Panel B) and Locomotion (Panel C). The data have been shown as Mean ± SEM for seven rats for each group. *P<0.05, 
**P<0.01 and ***P<0.001 as compared to saline control group.
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time interval required for reaction to pain [F (2, 
18)=20.084, P < 0.05; Figure 2, panel 2B] and increased 
loco-motor activity [F (2, 18)=34.655; P < 0.05; Figure 2, 
panel 3B]
3-3: The Impact of RSD on Memory Acquisition, 
Pain and Locomotor Activities in Presence and 
Absence of Nicotine and Mecamylamine
One-way ANOVA and post hoc Tukey analysis indicated 
that sub-threshold dose of nicotine and mecamylamine 
(that selected according to experiment 1) did not alter 
memory acquisition [F (2, 18) = 0.139; P > 0.05; Figure 3, 
panel 1 A] in the sham RSD rats. However, mecamylamine 
but not nicotine increased hot plate latency [F (2, 18) 
=15.008. P < 0.05; Figure 3, panel 1B].and loco-motor 
activity [F (2, 18)=4.933; P < 0.05; Figure 3, panel 1C].
The t test analysis showed that RSD could significantly 
decrease memory acquisition (t = 5.348, P < 0.05; Figure 3, 
panel 1) and loco-motor activity (t = 7.50, P < 0.05; Figure 
3, panel 3) but it did not alter time interval required for 
reaction to pain (t = 12.50, P > 0.05; Figure 3, panel 2) 
compared to sham control group.
One-way ANOVA and post hoc Tukey test showed that 
nicotine and mecamylamine restored amnesia induced 
by RSD  [F (2, 18)=14.618; P < 0.05; Figure 3, panel 1B] 
but both of drugs did not alter time interval required for 
reaction to pain [F (2, 18)=5.215, P > 0.05; Figure 3, panel 
2B], while mecamylamine but not nicotine increased 
loco-motor activity in RSD rats [F (2, 18)=8.373, P < 0.05; 
Figure 3, panel 3B].
Discussion
Investigating the Impact of Nicotine and 
Mecamylamine on Behaviors in Normal Animals
The present study showed that some doses of nicotine 
caused memory acquisition reduction in normal rats, 
while some other doses of this drug did not affect 
memory; on the other hand, all doses of mecamylamine 
led to memory reduction. Moreover, the study also 
showed no significant difference in TSD and RSD sham 














































































































Figure 2. The Impact of Pre-training Intra-CA1 Injection of Nicotine or Mecamylamine on Memory Acquisition (Panel 1), Latency to Paw 
Withdraw (Panel 2) and Locomotor Activity (Panel 3) on Sham of TSD (A) or TSD Rats (B). The data have been shown as Mean ± SEM 
for seven rats per group. *P<0.05, **P<0.01 and ***P<0.001 as compared to saline/sham of TSD control group. +P<0.05, ++P<0.01 and 
+++P<0.001 as compared to saline/TSD control group.
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Some studies have referred to the role of acetyl 
choline34 in learning and memory through its importance 
in neuronal plasticity and have introduced it as a key 
neuro-transmitter (which produces the driving force 
of neuronal activity to establish learning and memory 
in hippocampal system).35,36 Muscarinic and nicotinic 
cholinergic receptors have modulatory effects on acetyl 
choline performance.37 Different experimental studies 
on humans and animals have led to contradictory results 
regarding the effects of nicotine which is a nicotinic acetyl 
choline specific stimulus. Although some researchers have 
reported nicotine-induced memory improvement, some 
others have not observed any effects or have conversely 
reported its negative effects.24
Some studies show that stimulation of acetyl choline 
nicotinic receptor with one application of nicotine in 
normal rats can improve short-term memory, while it 
doesn’t affect long-term memory.24
Other studies state that there is a reverse U-shaped 
response dose for cholinergic system activity. This pattern 
suggests that Ach has an optimal range for successful 
activity in hippocampus.38-40 Although this pattern does 
not describe different behavioral responses sufficiently, 
molecular and neurochemical effects of nicotine suggest 
a particular molecular framework leading to different 
behaviors.
It seems that the primary aim of nicotine in brain 
includes depolarization and stimulation of nAchRs, while 
its secondary effects include releasing glutamate and 
GABA inside a tissue. Therefore, according to another 
theory which can justify different effects of nicotine, these 
various functions are a consequence of different activities 
by nicotinic and non-nicotinic receptors. Different 
antagonists of acetyl choline nicotinic receptor may apply 
their various effects on memory performance through 
selective function of these compounds in subtypes of 
nicotinic receptors or non-nicotinic receptors.24
According to some findings, mecamylamine can 
have different separate effects on learning and memory 
processes.41 Some findings suggest that application of 
mecamylamine in some doses may lead to impairment of 
cognitive functions through disruption of anterior striatal 
BDNF signaling.42,43
In this study, mecamylamine is also expected to reduce 
memory by using different methods such as reducing 
BDNF signaling, blocking nAchRs, decreasing the 
concentration of Ach and decreasing the plasticity of the 
neuron.
Figure 3. The Impact of Pre-training intra-CA1 Injection of Nicotine or Mecamylanine on memory acquisition (panel 1), latency to paw 
withdraw (Panel 2) and Locomotor Activity (Panel 3) on Sham of RSD (REM sleep deprivation; A) or RSD rats (B). The data have been shown 
as Mean ± SEM for seven rats per group. *P < 0.05, **P < 0.01 and ***P < 0.001 as compared to saline/sham of RSD control group. +P < 0.05, 
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The Impact of TSD and RSD on Memory Acquisition, 
Pain and Locomotor Activity
SD affects different phases of memory formation.6 
Findings which have been acquired from research done 
on human and animals indicate that even a slight SD 
or mild sleep disorder will weaken the establishment of 
hippocampus-dependent new memory. Although many 
studies show that sleep disorder will be able to affect 
hippocampus-dependent memory before learning, it 
is not obvious if this deficiency is due to impairment of 
memory coding or weak memory consolidation after it.11
In the present study both TSD and RSD led to reduction 
of memory acquisition. In line with our results, Tadavarty 
et al found that SD increases LTD in hippocampus CA1 
area significantly.44 Given the fact that increased LTD 
can lead to consistent reduction in learning and memory 
consolidation,45 researchers suggest that increased LTD 
may be associated with cognitive deficiencies observed 
after SD.44 Consistent with these findings, Kopp et al 
showed that SD weakens LTP, while it induces LTD.46
Studies have also shown that REM sleep SD leads to 
significant deficit in maintaining hippocampal LTP, while 
NREM sleep disorders do not represent any deficits in 
LTP.12 It has been also proposed that adenosine which is 
one of neuronal modulators in brain may possibly have 
a role in learning and memory impairment induced by 
SD.47,48 Adenosine is observed because of damage in ATP 
and convolute adenosine monophosphate25,48 whose 
concentration goes up in the period of wakefulness and 
goes down while asleep.49,50 Florian suggests that ATP 
derived from Astrocytes as well as increased adenosine 
during SD affect hippocampus synaptic plasticity and 
hippocampus-dependent memory.51 SD can also prevent 
cAMP-PKA signaling in hippocampus and accordingly 
interrupts some forms of LTP in hippocampus.13
The cAMP signaling suppression due to SD can influence 
neuronal plasticity and memory operations through 
different procedures. Weak cAMP-PKA signaling may 
have a direct influence on phosphorylation and expression 
of glutamate receptors subtypes existing in cellular 
membrane or can lead to reduction of phosphorylation 
and activity of CREB protein transcription agent which 
regulates expression of a wide range of genes associated 
to synaptic plasticity, while the level of protein and BDNF 
mRNA which is an important neurogenesis promoter will 
decrease.52,53
Another important component which may cause 
cognitive disorders following SD is reduction of 
expression and function of NMDA receptors which can 
play a significant role in all three memory stages including 
learning, consolidation, and retrieval.54 For example, while 
genetic improvement of performance in NMDA receptor 
leads to memory improvement in mature rats,55 receptors’ 
blockage leads to learning and memory disorder.56
In addition to changes in performance and expression 
of glutamate receptors, SD can also affect the amount of 
glutamate release,56 so that high amounts of glutamate 
due to long-term wakefulness will lower AMPA and 
NMDA receptors expression which will subsequently 
lead to unfavorable performance and eventually neuronal 
plasticity disorder.58 In the present study, TSD and RSD led 
to a significant decrease in memory which was consistent 
with other studies and according to our expectation.
The Impact of Nicotine and Mecamylamine on 
Behaviors-Induced by RSD and TSD
BF includes subcortical structures rich in cholinergic 
neurons and can play a significant role in activation of 
cortex; moreover, its damage in many neurodegenerative 
diseases such as Alzheimer leads to multiple problems 
in attention, learning, and memory.20 Primary clinical 
studies have not reported changes in the number, 
structure, and performance of mAchRs cholinergic 
muscarinic receptors, while reduction of some subtypes 
of cholinergic nicotinic receptors has been observed in 
cortex and hippocampus.20
BF cholinergic neurons are only a small range of 
neuron population in this structure and other neurons 
include glutamatergic and GABAergic subtypes showing 
different firing and activation patterns during sleep and 
wakefulness, and cortical activity.20 Studies show that 
activation of BF cholinergic neurons through PKA/
PKC signaling pathways and their intra-hippocampus 
dependent proteins can lead to attention, learning, and 
memory.25
In this study, injection of nicotine has probably 
improved memory in both TSD and RSD through 
activation of cholinergic system.
Some studies state that nicotine increases activity 
of cholinergic nicotinic receptors (nAchRs), 
particularly inside hippocampus,59 increases the level of 
attention,40,60 and can strengthen memory acquisition 
and consolidation.59 Nicotine can also lead to release 
of other neuro-transmitters such as serotonin, GABA, 
norepinephrine, and glutamate all of which are necessary 
for memory formation, through activation of nAchRs 
which are presynaptic.59
In our study, according to our expectations and 
prediction in both groups, TSD and RSD intervention 
with nicotine improved memory acquisition. It seems that 
activating nAchRs initially increases intracellular Ca2+ by 
activating many signaling pathways such as:
- Increased activity of NMDA receptors, LTP 
enhancement
- Enhancing PKC activation and signaling pathways of 
ERK1,2 and AMPA
- Enhancing PKA /Camp activation and activating 
ERK1 signaling path 2; and
- Increased expression of CREB gene which leads to 
memory improvement.34,61
Nicotine intervention can also enhance memory 
acquisition through effects on other neurotransmitters 
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involved in memory processes. Intervention with 
mecamylamine improved memory acquisition in both 
TSD and RSD groups despite expectation.
It is proposed that most effects of mecamylamine 
on attention and cognitive activities can be justified by 
NMDA receptors blockage.59 Some findings indicate that 
glutamate increases during long-term wakefulness and 
REM sleep, while it decreases in the period of NREM 
sleep.58 On the other hand, we know that increased 
glutamate concentration can induce apoptosis.62 
Therefore, during deprivation of NREM and following 
increased glutamate concentration, mecamylamine 
can decrease negative effects of increased glutamate 
level through NMDA receptors blockage.63 We know 
that activation of dopaminergic D2 receptors decreases 
cAMP/PKA.64
Therefore, mecamylamine, as a dopaminergic 
antagonistic system, increases attention and improves 
memory through dopaminergic receptors blockage59 and 
increasing cAMP levels. Treatment with mecamylamine 
can also modulate negative effects of SD in RSD 
conditions.
As it was mentioned, it is probable that mecamylamine 
exerts many of its effects on memory by activating or 
blocking other receptors in the CA1 and activating 
some effective signaling pathways to improve memory 
performance. 
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